This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yancik R (1997) Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 22: 3–9
von der Maase H et al. (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18: 3068–3077
Balducci L et al. (2000) Cancer in the frail patient. A coming epidemic. Hematol Oncol Clin North Am 14: 235–250, xi
Repetto L et al. (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20: 494–502
Acknowledgements
The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- ECOG PERFORMANCE STATUS
-
A 0 (fully active) to 5 (dead) scoring system to assess the wellbeing of cancer patients and their ability to perform ordinary tasks
Rights and permissions
About this article
Cite this article
Mohile, S., Stadler, W. Do elderly patients have a worse outcome in response to platinum-based therapy for metastatic urothelial cancer?. Nat Rev Clin Oncol 2, 392–393 (2005). https://doi.org/10.1038/ncponc0247
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0247